Herbal Extracts and Phytochemicals: Plant Secondary Metabolites and the Enhancement of Human Brain Function1
Identifieur interne : 000205 ( Main/Exploration ); précédent : 000204; suivant : 000206Herbal Extracts and Phytochemicals: Plant Secondary Metabolites and the Enhancement of Human Brain Function1
Auteurs : David O. Kennedy ; Emma L. WightmanSource :
- Advances in Nutrition [ 2161-8313 ] ; 2011.
Abstract
Humans consume a wide range of foods, drugs, and dietary supplements that are derived from plants and which modify the functioning of the central nervous sytem (CNS). The psychoactive properties of these substances are attributable to the presence of plant secondary metabolites, chemicals that are not required for the immediate survival of the plant but which are synthesized to increase the fitness of the plant to survive by allowing it to interact with its environment, including pathogens and herbivorous and symbiotic insects. In many cases, the effects of these phytochemicals on the human CNS might be linked either to their ecological roles in the life of the plant or to molecular and biochemical similarities in the biology of plants and higher animals. This review assesses the current evidence for the efficacy of a range of readily available plant-based extracts and chemicals that may improve brain function and which have attracted sufficient research in this regard to reach a conclusion as to their potential effectiveness as nootropics. Many of these candidate phytochemicals/extracts can be grouped by the chemical nature of their potentially active secondary metabolite constituents into alkaloids (caffeine, nicotine), terpenes (ginkgo, ginseng, valerian,
Url:
DOI: 10.3945/an.110.000117
PubMed: 22211188
PubMed Central: 3042794
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Pmc, to step Corpus: 000315
- to stream Pmc, to step Curation: 000203
- to stream Pmc, to step Checkpoint: 000132
- to stream Ncbi, to step Merge: 000096
- to stream Ncbi, to step Curation: 000096
- to stream Ncbi, to step Checkpoint: 000096
- to stream Main, to step Merge: 000205
- to stream Main, to step Curation: 000205
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Herbal Extracts and Phytochemicals: Plant Secondary Metabolites and the Enhancement of Human Brain Function<xref ref-type="fn" rid="fn1"><sup>1</sup>
</xref>
</title>
<author><name sortKey="Kennedy, David O" sort="Kennedy, David O" uniqKey="Kennedy D" first="David O." last="Kennedy">David O. Kennedy</name>
</author>
<author><name sortKey="Wightman, Emma L" sort="Wightman, Emma L" uniqKey="Wightman E" first="Emma L." last="Wightman">Emma L. Wightman</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PMC</idno>
<idno type="pmid">22211188</idno>
<idno type="pmc">3042794</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3042794</idno>
<idno type="RBID">PMC:3042794</idno>
<idno type="doi">10.3945/an.110.000117</idno>
<date when="2011">2011</date>
<idno type="wicri:Area/Pmc/Corpus">000315</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">000315</idno>
<idno type="wicri:Area/Pmc/Curation">000203</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">000203</idno>
<idno type="wicri:Area/Pmc/Checkpoint">000132</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Checkpoint">000132</idno>
<idno type="wicri:Area/Ncbi/Merge">000096</idno>
<idno type="wicri:Area/Ncbi/Curation">000096</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000096</idno>
<idno type="wicri:doubleKey">2161-8313:2011:Kennedy D:herbal:extracts:and</idno>
<idno type="wicri:Area/Main/Merge">000205</idno>
<idno type="wicri:Area/Main/Curation">000205</idno>
<idno type="wicri:Area/Main/Exploration">000205</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">Herbal Extracts and Phytochemicals: Plant Secondary Metabolites and the Enhancement of Human Brain Function<xref ref-type="fn" rid="fn1"><sup>1</sup>
</xref>
</title>
<author><name sortKey="Kennedy, David O" sort="Kennedy, David O" uniqKey="Kennedy D" first="David O." last="Kennedy">David O. Kennedy</name>
</author>
<author><name sortKey="Wightman, Emma L" sort="Wightman, Emma L" uniqKey="Wightman E" first="Emma L." last="Wightman">Emma L. Wightman</name>
</author>
</analytic>
<series><title level="j">Advances in Nutrition</title>
<idno type="ISSN">2161-8313</idno>
<idno type="eISSN">2156-5376</idno>
<imprint><date when="2011">2011</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en"><p>Humans consume a wide range of foods, drugs, and dietary supplements that are derived from plants and which modify the functioning of the central nervous sytem (CNS). The psychoactive properties of these substances are attributable to the presence of plant secondary metabolites, chemicals that are not required for the immediate survival of the plant but which are synthesized to increase the fitness of the plant to survive by allowing it to interact with its environment, including pathogens and herbivorous and symbiotic insects. In many cases, the effects of these phytochemicals on the human CNS might be linked either to their ecological roles in the life of the plant or to molecular and biochemical similarities in the biology of plants and higher animals. This review assesses the current evidence for the efficacy of a range of readily available plant-based extracts and chemicals that may improve brain function and which have attracted sufficient research in this regard to reach a conclusion as to their potential effectiveness as nootropics. Many of these candidate phytochemicals/extracts can be grouped by the chemical nature of their potentially active secondary metabolite constituents into alkaloids (caffeine, nicotine), terpenes (ginkgo, ginseng, valerian, <italic>Melissa officinalis</italic>
, sage), and phenolic compounds (curcumin, resveratrol, epigallocatechin-3-gallate, <italic>Hypericum perforatum</italic>
, soy isoflavones). They are discussed in terms of how an increased understanding of the relationship between their ecological roles and CNS effects might further the field of natural, phytochemical drug discovery.</p>
</div>
</front>
</TEI>
<affiliations><list></list>
<tree><noCountry><name sortKey="Kennedy, David O" sort="Kennedy, David O" uniqKey="Kennedy D" first="David O." last="Kennedy">David O. Kennedy</name>
<name sortKey="Wightman, Emma L" sort="Wightman, Emma L" uniqKey="Wightman E" first="Emma L." last="Wightman">Emma L. Wightman</name>
</noCountry>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Psychologie/explor/DanceTherParkinsonV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000205 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000205 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Psychologie |area= DanceTherParkinsonV1 |flux= Main |étape= Exploration |type= RBID |clé= PMC:3042794 |texte= Herbal Extracts and Phytochemicals: Plant Secondary Metabolites and the Enhancement of Human Brain Function1 }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:22211188" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \ | NlmPubMed2Wicri -a DanceTherParkinsonV1
This area was generated with Dilib version V0.6.35. |